Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
2.730
-0.010 (-0.36%)
At close: Sep 11, 2026, 4:00 PM EDT
2.779
+0.049 (1.81%)
After-hours: Sep 11, 2026, 7:58 PM EDT
Cabaletta Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 225.1 | 82.98 | 163.96 | 193.24 | 81.61 | 122.22 |
Short-Term Investments | - | 50.62 | - | 48.01 | 24.94 | - |
Cash & Short-Term Investments | 225.1 | 133.6 | 163.96 | 241.25 | 106.55 | 122.22 |
Cash Growth | 15.63% | -18.52% | -32.04% | 126.43% | -12.83% | 12.48% |
Prepaid Expenses | 5.93 | 5.27 | 2.71 | 3.24 | 2.29 | 2.32 |
Total Current Assets | 231.03 | 138.87 | 166.68 | 244.49 | 108.83 | 124.54 |
Property, Plant & Equipment | 19.49 | 21.05 | 16.08 | 7.45 | 7.57 | 1.44 |
Other Long-Term Assets | 6.21 | 5.16 | 2.29 | 1.71 | 0.57 | 0.36 |
Total Assets | 256.73 | 165.08 | 185.05 | 253.65 | 116.97 | 126.34 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 5.81 | 6.64 | 4.92 | 4.55 | 2.46 | 2.33 |
Accrued Expenses | 14.55 | 19.22 | 12.15 | 7.85 | 4.81 | 5.99 |
Current Portion of Leases | 19.49 | 24.22 | 9.98 | 3.56 | 2.18 | - |
Other Current Liabilities | 0.06 | 0.08 | 0.04 | 0.04 | 0.04 | 0.05 |
Total Current Liabilities | 39.91 | 50.15 | 27.09 | 15.99 | 9.49 | 8.38 |
Long-Term Leases | 6.23 | 2.88 | 5.63 | 1.46 | 2.96 | - |
Total Liabilities | 46.14 | 53.03 | 32.71 | 17.45 | 12.45 | 8.38 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0 | 0 | - | - | - |
Additional Paid-In Capital | 822.08 | 628.98 | 501.44 | 469.4 | 270.13 | 230.54 |
Retained Earnings | -611.49 | -516.96 | -349.1 | -233.24 | -165.56 | -112.59 |
Comprehensive Income & Other | - | 0.03 | - | 0.04 | -0.05 | - |
Total Common Equity | 210.59 | 112.05 | 152.34 | 236.2 | 104.52 | 117.96 |
Shareholders' Equity | 210.59 | 112.05 | 152.34 | 236.2 | 104.52 | 117.96 |
Total Liabilities & Equity | 256.73 | 165.08 | 185.05 | 253.65 | 116.97 | 126.34 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 25.71 | 27.1 | 15.6 | 5.02 | 5.14 | - |
Net Cash (Debt) | 199.39 | 106.5 | 148.36 | 236.23 | 101.41 | 122.22 |
Net Cash Growth | 17.43% | -28.21% | -37.20% | 132.95% | -17.03% | 12.48% |
Net Cash Per Share | 1.70 | 1.33 | 3.00 | 5.77 | 3.46 | 4.75 |
Filing Date Shares Outstanding | 169.55 | 111.32 | 50.74 | 48.24 | 31.34 | 28.98 |
Total Common Shares Outstanding | 167.73 | 100.48 | 50.74 | 47.82 | 29.45 | 28.93 |
Working Capital | 191.12 | 88.72 | 139.59 | 228.5 | 99.35 | 116.16 |
Book Value Per Share | 1.26 | 1.12 | 3.00 | 4.94 | 3.55 | 4.08 |
Tangible Book Value | 210.59 | 112.05 | 152.34 | 236.2 | 104.52 | 117.96 |
Tangible Book Value Per Share | 1.26 | 1.12 | 3.00 | 4.94 | 3.55 | 4.08 |
Machinery | - | 8.96 | 8.14 | 6.22 | 4.83 | 2.57 |
Leasehold Improvements | - | 0.11 | 0.11 | 0.11 | 0.11 | 0.06 |